Oculus Innovative Sciences Microcyn Technology Data to be Presented by Researchers at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy Sep 17, 2007
Oculus Innovative Sciences Provides Update of Phase II Study for Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers Sep 17, 2007
Oculus Innovative Sciences to Conduct Conference Call Update on Phase II Study of Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers Sep 14, 2007
Oculus Innovative Sciences to Present at First Albany Capital Regenerative Technologies Conference Sep 6, 2007
Oculus Innovative Sciences Schedules Fiscal First Quarter 2008 Financial Results Release and Conference Call Aug 3, 2007
Oculus Innovative Sciences Announces Results From Anti-Inflammatory Study Using Microcyn(R) Technology Jun 26, 2007
